Clinical feature Statistical test Significant miRs Associated with                 Associated with Time to Death Cox regression test N=13 shorter survival N=9 longer survival N=4 AGE Spearman correlation test N=22 older N=15 younger N=7 NEOPLASM DISEASESTAGE Kruskal-Wallis test N=63 PATHOLOGY T STAGE Spearman correlation test N=43 higher stage N=20 lower stage N=23 PATHOLOGY N STAGE Wilcoxon test N=104 class1 N=104 class0 N=0 PATHOLOGY M STAGE Kruskal-Wallis test N=12 GENDER Wilcoxon test N=2 male N=2 female N=0 HISTOLOGICAL TYPE Kruskal-Wallis test N=208 RADIATIONS RADIATION REGIMENINDICATION Wilcoxon test N=26 yes N=26 no N=0 RADIATIONEXPOSURE Wilcoxon test N=0 EXTRATHYROIDAL EXTENSION Kruskal-Wallis test N=85 COMPLETENESS OF RESECTION Kruskal-Wallis test N=1 NUMBER OF LYMPH NODES Spearman correlation test N=80 higher number.of.lymph.nodes N=47 lower number.of.lymph.nodes N=33 MULTIFOCALITY Wilcoxon test N=1 unifocal N=1 multifocal N=0 TUMOR SIZE Spearman correlation test N=11 higher tumor.size N=5 lower tumor.size N=6 RACE Kruskal-Wallis test N=1 ETHNICITY Wilcoxon test N=5 not hispanic or latino N=5 hispanic or latino N=0